University of Florida neuroscientists, Laura Ranum, Ph.D., and Tao Zu, Ph.D., showed in a mouse-model study that metformin, a widely prescribed drug approved by the U.S. Food and Drug Administration to treat Type 2 diabetes, reduces levels of specific mutant proteins central to the most common genetic form of ALS and frontotemporal dementia, or FTD, … Continue reading New Study Shows Common Diabetes Drug Improves Symptoms in Genetic Form of ALS in Mice